文献速递中毒与环境急症儿科与产科急症

家庭成员阿片类药物处方与青少年及年轻成人阿片类药物过量的关联

Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults.
PubMed 文献 · JAMA Netw Open · 2020-03-02
一句话结论青少年暴露于家庭成员阿片类药物处方与药物性阿片过量风险升高相关(aHR 2.17),且与自身处方叠加时风险更高(aHR 12.99)。

该队列研究纳入2006年参保Kaiser Permanente Colorado健康计划的45145个家庭单元、共72040名11至26岁青少年及年轻成人,随访至2018年6月。暴露为过去一个月家庭成员及青少年本人配取的阿片类药物处方与剂量。主要结局为生命记录中的致死性药物性阿片过量及急诊和住院环境中识别的非致死性药物性阿片过量。结果显示,过去一个月家庭成员有阿片类药物处方与药物性阿片过量风险升高相关(aHR 2.17;95%CI 1.24-3.79),独立于青少年自身阿片处方(aHR 6.62;95%CI 3.39-12.91);青少年与家庭成员同时暴露时风险大幅升高(aHR 12.99;95%CI 5.08-33.25)。作者认为需要针对青少年和家庭的进一步干预,包括就阿片类药物对家庭中青少年的风险对患者进行咨询。

要点

  • 过去一个月家庭成员有阿片类药物处方与青少年药物性阿片过量风险升高相关(aHR 2.17;95%CI 1.24-3.79),独立于青少年自身阿片处方。
  • 青少年自身阿片处方与药物性阿片过量风险升高相关(aHR 6.62;95%CI 3.39-12.91)。
  • 青少年与家庭成员同时暴露于阿片类药物处方时过量为风险大幅升高(aHR 12.99;95%CI 5.08-33.25)。
  • 家庭成员过去一个月总吗啡毫克当量≥600 MME与青少年过量风险升高相关(aHR 2.93;95%CI 1.55-5.56),而>0至<200 MME及200至<600 MME与0 MME比较未达统计学显著。
  • 作者认为需要针对青少年和家庭的进一步干预,包括就阿片类药物对家庭中青少年的风险对患者进行咨询。

适用人群与场景

  • 2006年参保Kaiser Permanente Colorado健康计划的45145个家庭单元中的72040名11至26岁青少年及年轻成人,随访至2018年6月。
  • 随访期间平均(标准差)年龄19.3(3.7)岁;36646名(50.9%)为女孩和女性。

研究设计与关键结果

  • 研究类型为队列研究,样本量72040名青少年及年轻成人,嵌套于45145个家庭单元,随访至2018年6月。
  • 随访期间26284名青少年(36.5%)至少配取1次阿片类药物处方,47461名青少年(65.9%)至少1名家庭成员有阿片类药物处方。
  • 过去一个月家庭成员有阿片类药物处方与药物性阿片过量风险升高相关(aHR 2.17;95%CI 1.24-3.79),独立于青少年自身阿片处方(aHR 6.62;95%CI 3.39-12.91)。
  • 青少年与家庭成员同时暴露于阿片类药物处方与过量风险大幅升高相关(aHR 12.99;95%CI 5.08-33.25)。
  • 家庭成员过去一个月总MME与青少年过量:0 MME vs >0至<200 MME的aHR 1.39(95%CI 0.51-3.81);0 MME vs 200至<600 MME的aHR 1.49(95%CI 0.59-3.77);0 MME vs ≥600 MME的aHR 2.93(95%CI 1.55-5.56)。

证据类型、等级与局限

  • 证据类型为队列研究。
  • 作者结论指出需要针对青少年和家庭的进一步干预,包括就阿片类药物对家庭中青少年的风险对患者进行咨询。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为需要针对青少年和家庭的进一步干预,包括就阿片类药物对家庭中青少年的风险对患者进行咨询。
  • 研究显示青少年更常暴露于家庭成员配取的阿片类药物处方而非自身处方,过去一个月家庭成员有阿片处方与青少年药物性阿片过量风险升高相关(aHR 2.17;95%CI 1.24-3.79)。
  • 青少年自身阿片处方与家庭成员阿片处方同时存在时过量风险大幅升高(aHR 12.99;95%CI 5.08-33.25),提示评估青少年过量风险时需同时了解家庭成员的阿片处方情况。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Family members are cited as a common source of prescription opioids used for nonmedical reasons. However, the overdose risk associated with exposure to opioids prescribed to family members among adolescents and young adults is not well established.

OBJECTIVE: To assess the association of opioids prescribed to family members with pharmaceutical opioid overdose among youth.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study included 45 145 family units with a total of 72 040 adolescents and young adults aged 11 to 26 years enrolled in a Kaiser Permanente Colorado health plan in 2006 and observed through June 2018.

EXPOSURES: Opioid prescriptions and dosage dispensed to family members and youth in the past month.

MAIN OUTCOMES AND MEASURES: Fatal pharmaceutical opioid overdoses identified in vital records and nonfatal pharmaceutical opioid overdoses identified in emergency department and inpatient settings. Time to first overdose was modeled using Cox regression.

RESULTS: The study population consisted of 72 040 adolescents and young adults (mean [SD] age across follow-up, 19.3 [3.7] years; 36 646 [50.9%] girls and women) nested in 45 145 family units. Youth were more commonly exposed to prescription opioids dispensed to a family member than through their own prescriptions. During follow-up, 26 284 youth (36.5%) filled at least 1 opioid prescription, and 47 461 youth (65.9%) had at least 1 family member with a prescription. Exposure to family members with opioid prescriptions in the past month was associated with increased risk of pharmaceutical opioid overdose (adjusted hazard ratio [aHR], 2.17; 95% CI, 1.24-3.79) independent of opioids prescribed to youth (aHR, 6.62; 95% CI, 3.39-12.91). Concurrent exposure to opioid prescriptions from youth and family members was associated with substantially increased overdose risk (aHR, 12.99; 95% CI, 5.08-33.25). High dosage of total morphine milligram equivalents (MME) prescribed to family members in the past month was associated with youth overdose (0 MME vs >0 to <200 MME: aHR, 1.39; 95% CI, 0.51-3.81; 0 MME vs 200 to <600 MME: aHR, 1.49; 95% CI, 0.59-3.77; 0 MME vs ≥600 MME: aHR, 2.93; 95% CI, 1.55-5.56).

CONCLUSIONS AND RELEVANCE: In this study of youth linked to family members, exposure to family members' prescribed opioids was associated with increased risk of pharmaceutical opioid overdose, independent of opioids prescribed to youth. Further interventions targeting youth and families are needed, including counseling patients about the risks of opioids to youth in their families.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Nguyen AP, Glanz JM, Narwaney KJ, et al. Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults. JAMA Netw Open. 2020. PMID: 32219404. doi:10.1001/jamanetworkopen.2020.1018

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。